Full-Time

VP – Medical Affairs and Patient Advocacy

Editas Medicine

Editas Medicine

201-500 employees

Clinical stage genome editing for disease treatment

Biotechnology

Expert

Cambridge, MA, USA

Required Skills
Communications
Requirements
  • Hands on and independent self-starter capable of wearing multiple hats and a drive to build an organization from the ground up
  • Previous pharmaceuticals industry experience in a Medical Affairs leadership role, including a deep understanding of related regulations and compliance considerations
  • Demonstrated ability to influence across a matrix structure, and to collaborate in a cross-functional environment
  • Able to establish relationships with different groups of internal/external stakeholders to obtain input and buy in to medical/development strategy and clinical study design
  • Provides motivational leadership to the organization and improve its performance through the creation of processes to obtain early expert, patient, and payer input into clinical candidate selection, development strategy, and clinical trial design
  • Strong problem-solver and business acumen
  • Highly organized and proficient in long range planning to support business and clinical needs to support each step of research and development
  • Excellent verbal, written and interpersonal skills and communication skills
  • A minimum of ten years of experience in the pharmaceutical/biotechnology industry
  • MD, MD/PhD, PharmD or PhD
  • Experience or high comfort level in supporting clinical programs across multiple therapeutic areas, and bridging late to early development
  • Strong understanding of Medical Strategy, Medical Communications, and importance of Patient Advocacy in advancing portfolios focusing on rare disease
  • Experience in Hematology and other Rare Disease Drug Development
  • Familiarity with gene and/or cell therapy a plus
  • Less than 25% travel at this time, but may increase depending upon projects and portfolio
Responsibilities
  • Establish networks of therapeutic area thought leaders, will provide feedback, and participate in the research and development strategy across the product life cycle and different indications
  • Translate external input, clinical knowledge, competitive information, and patient feedback to inform on company goals, selection of products candidates, and development strategy
  • Provide input into developing clinical research protocols
  • Develop health outcomes research for long-term data and return on investment
  • Engage with patient advocacy groups to encourage early patient input into development strategy, open up opportunities for study awareness, and assist study feasibility and enrollment
  • Proactively identify or create outreach or support activities to allow for patient engagement, feedback, or assist access to clinical trials or treatment
  • Lead and provide input into external communication to external stakeholders, including development of key company messaging
  • Cross functionally align on internal and external messaging, including communications and publication planning
  • Assist clinical operations in developing site, investigator, and patient educational materials
  • Create internal awareness of company compliance, and structure for external
  • Engagement
  • Provide assessments of product opportunities and threats
  • Develop strategic imperatives and tactical plans to enhance healthcare practitioner education to improve patient outcomes
  • Collaborate with Commercial, Legal, and Regulatory for development and review of labelling, advertising and promotional materials

Editas Medicine stands out as a leader in the field of genomic medicine, leveraging the potential of CRISPR gene editing technology to develop treatments for serious diseases. The company fosters a vibrant culture, encouraging collaboration and resilience among its team of 'Editors', and is committed to manufacturing and commercializing durable, precision genomic medicines. With a robust pipeline of treatments in development, Editas Medicine is not only repairing broken genes but also shaping the future of medicine.

Company Stage

IPO

Total Funding

$884.6M

Headquarters

Cambridge, Massachusetts

Founded

2013

Growth & Insights
Headcount

6 month growth

11%

1 year growth

25%

2 year growth

11%
INACTIVE